IVF and breast cancer: a systematic review and meta-analysis
- PMID: 23884897
- DOI: 10.1093/humupd/dmt034
IVF and breast cancer: a systematic review and meta-analysis
Abstract
Background: The effects of controlled ovarian hyperstimulation (COH) for IVF in terms of breast cancer risk remain controversial, despite the hormone-dependent nature of the latter.
Methods: Eligible studies up to 15 February 2013 were identified and pooled effect estimates for relative risk (RR) were calculated separately for the investigations using the general population and those using infertile women, as a reference group. Fixed- or random-effects models were implemented and subgroup analyses were performed, as appropriate.
Results: Eight cohort studies were synthesized, yielding a total cohort size of 1,554,332 women among whom 14,961 incident breast cancer cases occurred, encompassing 576 incident breast cancer cases among women exposed to IVF. No significant association between IVF and breast cancer was observed either in the group of studies treating the general population (RR = 0.91, 95% confidence interval (CI): 0.74-1.11) or infertile women (RR = 1.02, 95% CI: 0.88-1.18), as a reference group. Of note were the marginal associations, protective for pregnant and/or parous women after IVF (pooled effect estimate = 0.86, 95% CI: 0.73-1.01) and adverse for women <30 years at first IVF treatment (pooled effect estimate = 1.64, 95% CI: 0.96-2.80).
Conclusions: At present, COH for IVF does not seem to impart increased breast cancer risk. Longer follow-up periods, comparisons versus infertile women, subgroup analyses aiming to trace vulnerable subgroups, adjustment for various confounders and larger informative data sets are needed before conclusive statements for the safety of the procedure are reached.
Keywords: IVF; breast cancer; hormones; infertility; meta-analysis.
Similar articles
-
Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysis.Hum Reprod Update. 2013 Mar-Apr;19(2):105-23. doi: 10.1093/humupd/dms051. Epub 2012 Dec 18. Hum Reprod Update. 2013. PMID: 23255514 Review.
-
Breast and ovarian cancer incidence after infertility and in vitro fertilisation.Lancet. 1995 Oct 14;346(8981):995-1000. doi: 10.1016/s0140-6736(95)91687-3. Lancet. 1995. PMID: 7475593
-
Ovarian Stimulation for In Vitro Fertilization and Long-term Risk of Breast Cancer.JAMA. 2016 Jul 19;316(3):300-12. doi: 10.1001/jama.2016.9389. JAMA. 2016. PMID: 27434442
-
Melanoma risk after ovarian stimulation for in vitro fertilization.Hum Reprod. 2015 May;30(5):1216-28. doi: 10.1093/humrep/dev023. Epub 2015 Mar 4. Hum Reprod. 2015. PMID: 25743782
-
In vitro fertilization and breast cancer risk: a review.Int J Fertil Womens Med. 2005 Nov-Dec;50(6):259-66. Int J Fertil Womens Med. 2005. PMID: 16526416 Review.
Cited by
-
Specialty Grand Challenge-Assisted Reproduction.Front Reprod Health. 2021 Jul 26;3:551499. doi: 10.3389/frph.2021.551499. eCollection 2021. Front Reprod Health. 2021. PMID: 36304062 Free PMC article. No abstract available.
-
Fertility treatment and breast-cancer incidence: meta-analysis.BJS Open. 2022 Jan 6;6(1):zrab149. doi: 10.1093/bjsopen/zrab149. BJS Open. 2022. PMID: 35143625 Free PMC article.
-
Gonadotrophin stimulation and risk of relapse in breast cancer.Hum Reprod Open. 2021 Jan 16;2021(1):hoaa061. doi: 10.1093/hropen/hoaa061. eCollection 2021. Hum Reprod Open. 2021. PMID: 33501382 Free PMC article.
-
Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers.Br J Cancer. 2018 May 1;119(3):357-363. doi: 10.1038/s41416-018-0139-1. Br J Cancer. 2018. PMID: 29937543 Free PMC article.
-
Ethics and regulation of inter-country medically assisted reproduction: a call for action.Isr J Health Policy Res. 2016 Dec 7;5:59. doi: 10.1186/s13584-016-0117-0. eCollection 2016. Isr J Health Policy Res. 2016. PMID: 27980721 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical